Ye (Gloria) Zheng
I am a second-year PhD candidate at the University of New South Wales (UNSW). I have a strong academic and research foundation developed across Australia’s leading medical research institutions. My journey began with a Bachelor of Science in Biotechnology (Honours) in China, followed by a Master of Biomedical Science at the Walter and Eliza Hall Institute of Medical Research (WEHI) and the University of Melbourne, where I investigated key signalling pathways in bowel cancer using cutting-edge 3D organoid models. As a Research Assistant at WEHI and UNSW, I have co-authored 7 publications, with 2 additional manuscripts under review, contributed to cross-disciplinary projects, played a central role in liquid biopsy innovation research, and trained over 10 lab members, further developing my expertise in cancer biology, multiplexed imaging technologies, and translational oncology.
Currently, my PhD research focuses on applying a world-first liquid biopsy pipeline leveraging single-cell multiplexing and AI-driven analytics to profile circulating tumour and immune cells for personalised cancer diagnostics and monitoring. We collaborate closely with interdisciplinary teams, including the UNSW AI Institute and clinical partners at Liverpool Hospital, aiming to transform precision oncology through innovative, minimally invasive patient-derived specimens targeting cancers with high burdens, such as non-small cell lung cancer and ovarian cancer. Recognised for academic excellence with competitive PhD scholarships and multiple awards, I am committed to advancing impactful, cross-cultural biomedical research that bridges innovation with real-world clinical and societal benefits.
Abstracts this author is presenting: